Letter to the Editor
Combination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy

https://doi.org/10.1016/j.cgh.2018.08.017Get rights and content

References (8)

  • R.P. Hirten

    Clin Gastroenterol Hepatol

    (2018)
  • S. Danese

    Ann Intern Med

    (2014)
  • B.E. Sands

    Inflamm Bowel Dis

    (2007)
  • R. Hirten

    Am J Gastroenterol

    (2015)
There are more references available in the full text version of this article.

Cited by (0)

Conflicts of interest This author discloses the following: Laurent Peyrin-Biroulet has received honoraria from Pfizer and Takeda. The remaining authors disclose no conflicts.

View full text